Michael Kody
Director of Finance/CFO bij Pharmaceutical Associates, Inc.
Profiel
Michael Kody is currently the Director at Felicitex Therapeutics, Inc. and the Chief Financial Officer at Pharmaceutical Associates, Inc. He previously worked as the Senior Vice President at Cencora, Inc. from 2007 to 2017, an Accountant at PricewaterhouseCoopers LLP from 1991 to 2007, and the Divisional President at Prasco LLC from 2019 to 2021.
Mr. Kody received his undergraduate degree from the University of Michigan.
Actieve functies van Michael Kody
Bedrijven | Functie | Begin |
---|---|---|
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Director/Board Member | - |
Pharmaceutical Associates, Inc.
Pharmaceutical Associates, Inc. Pharmaceuticals: MajorHealth Technology Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski. | Director of Finance/CFO | 01-01-2021 |
Eerdere bekende functies van Michael Kody
Bedrijven | Functie | Einde |
---|---|---|
CENCORA, INC. | Corporate Officer/Principal | 01-01-2017 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01-01-2007 |
Opleiding van Michael Kody
University of Michigan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CENCORA, INC. | Distribution Services |
Bedrijven in privébezit | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Commercial Services |
Pharmaceutical Associates, Inc.
Pharmaceutical Associates, Inc. Pharmaceuticals: MajorHealth Technology Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski. | Health Technology |